{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:37:29Z","timestamp":1790505449902,"version":"4.1.0"},"reference-count":44,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000402","name":"Kay Kendall Leukaemia Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:italic><jats:styled-content style=\"fixed-case\">IGHV<\/jats:styled-content><\/jats:italic> gene mutational status has prognostic significance in chronic lymphocytic leukaemia (<jats:styled-content style=\"fixed-case\">CLL<\/jats:styled-content>) but the percentage of mutations that correlates best with clinical outcome remains controversial. We initially studied 558 patients from diagnosis and found significant differences in median time to first treatment (<jats:styled-content style=\"fixed-case\">TTFT<\/jats:styled-content>) among Stage A patients and in overall survival (<jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>) for the whole cohort, between cases with &lt;97% and 97\u201398\u00b799% identity and between cases with 97\u201398\u00b799% and \u226599% identity, when cases from the <jats:italic><jats:styled-content style=\"fixed-case\">IGHV<\/jats:styled-content>3\u201021<\/jats:italic> Stereotype Subset #2 were excluded. A significant difference in progression\u2010free survival (PFS) and <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content> between those with &lt;97% and 97\u201398\u00b799% identity, but not between those with 97\u201398\u00b799% and \u226599% identity was also observed in a validation cohort comprising 460 patients in the <jats:styled-content style=\"fixed-case\">UK CLL<\/jats:styled-content>4 trial. Cox Regression analyses in the Stage A cohort revealed that a model which incorporated &lt;97%, 97\u201398\u00b799% and \u226599% identity as subgroups, was a better predictor of <jats:styled-content style=\"fixed-case\">TTFT<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">CLL<\/jats:styled-content> than using the 98% cut\u2010off. Multivariate analysis selected the three mutational subgroups as independent predictors of <jats:styled-content style=\"fixed-case\">TTFT<\/jats:styled-content> in Stage A patients, and of <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content> in the diagnostic cohort. This study highlights that cases with 97% identity should not be considered to have the same prognosis as other cases with mutated <jats:italic><jats:styled-content style=\"fixed-case\">IGHV<\/jats:styled-content><\/jats:italic> genes defined as &lt;98% identity to germline.<\/jats:p>","DOI":"10.1111\/bjh.13940","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T08:33:25Z","timestamp":1454661205000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The outcome of Chronic lymphocytic leukaemia patients with 97% <i><scp>IGHV<\/scp><\/i> gene identity to germline is distinct from cases with &lt;97% identity and similar to those with 98% identity"],"prefix":"10.1111","volume":"173","author":[{"given":"Zadie","family":"Davis","sequence":"first","affiliation":[{"name":"Department of Molecular Pathology Royal Bournemouth Hospital Sutton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Forconi","sequence":"additional","affiliation":[{"name":"Cancer Sciences University of Southampton Sutton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Parker","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathology Royal Bournemouth Hospital Sutton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gardiner","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathology Royal Bournemouth Hospital Sutton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Thomas","sequence":"additional","affiliation":[{"name":"Clinical Research Unit Bournemouth University Sutton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Catovsky","sequence":"additional","affiliation":[{"name":"Department of Haemato\u2010oncology Institute for Cancer Research Sutton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rose\u2010Zerilli","sequence":"additional","affiliation":[{"name":"Cancer Sciences University of Southampton Sutton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Strefford","sequence":"additional","affiliation":[{"name":"Cancer Sciences University of Southampton Sutton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oscier","sequence":"additional","affiliation":[{"name":"Department of Molecular Pathology Royal Bournemouth Hospital Sutton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-393694"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(14)00005-2"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-600874"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.7.2529"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07469.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.8515"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61125-8"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-244251"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1840"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.186"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2696"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404457"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1848"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06928.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.4161\/epi.22901"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.028639"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040544"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-099564"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2011.00480"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15260-9"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.025338"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-429282"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.098384"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-367417"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.308"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-556399"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14666"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.252"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-092882"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-3266"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.399"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-373159"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-012948"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-338855"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.98"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221309"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.2262"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3485"},{"key":"e_1_2_7_44_1","first-page":"465","article-title":"Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome","volume":"90","author":"Tobin G.","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-014-0812-3"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.13940","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.13940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T09:26:44Z","timestamp":1696325204000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.13940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1111\/bjh.13940"],"URL":"https:\/\/doi.org\/10.1111\/bjh.13940","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]},"assertion":[{"value":"2015-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-02-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}